Inhibition of cell differentiation: a critical mechanism for MYC-mediated carcinogenesis?

Javier Leon1, Nuria Ferrandiz, Juan C Acosta

  • 1Departamento de Biología Molecular, Facultad de Medicina, Instituto de Biomedicina y Biotecnología de Cantabria, Universidad de Cantabria-CSIC-IDICAN, Avda. Cardenal Herrera Oria s/n; Santander, Spain. leonj@unican.es

Insights

The oncogene MYC, crucial in cancer, inhibits cell differentiation by blocking key transcription factors, not just by promoting proliferation. This anti-differentiation role is vital for MYC-driven tumorigenesis and maintaining stemness.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The oncogene MYC is implicated in cancer, but its precise role in tumorigenesis remains unclear.
  • While MYC's role in promoting cell proliferation is well-studied, its impact on cell differentiation is also a significant, early-described activity.
  • Impaired cell differentiation is a hallmark of MYC-driven cancers, as evidenced by tumor regression and cell redifferentiation upon MYC inactivation in mouse models.

Purpose of the Study:

  • To elucidate the mechanisms by which MYC inhibits cell differentiation.
  • To explore the link between MYC's anti-differentiation function and its oncogenic potential.
  • To discuss the hypothesis that MYC acts as a shared pathway for maintaining stemness and driving oncogenesis.

Main Methods:

  • Review and discussion of existing models and experimental data on MYC's function in cell differentiation.
  • Analysis of MYC's role in blocking the upregulation of differentiation-specific transcription factors.
  • Examination of MYC's function in both proliferative and non-proliferative differentiation arrest models.

Main Results:

  • MYC inhibits cell differentiation by blocking the upregulation of critical transcription factors, independent of its effect on cell cycle progression.
  • Evidence suggests MYC can block differentiation even when cells are already in a proliferative arrest.
  • MYC's ability to reprogram differentiated cells into pluripotent stem cells highlights its role in maintaining stemness.

Conclusions:

  • MYC's inhibition of cell differentiation is a key mechanism in tumorigenesis, occurring through the suppression of differentiation-driving transcription factors.
  • MYC's dual role as a stemness factor and an oncogene likely involves common molecular pathways.
  • Understanding MYC's anti-differentiation function is crucial for developing novel cancer therapies targeting MYC-driven tumors.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.